DSIP 5mg

Contents

Use this guide as a structured review page. The same headings appear for every protocol so clients and the care team can scan the page consistently.

Quickstart Highlights

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain tissue and studied for its effects on sleep architecture and stress modulation[1][2]. Research indicates DSIP may promote delta-wave (slow-wave) sleep, modulate cortisol and ACTH levels, and exhibit stress-protective properties[3][4]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

• Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
• Typical daily range: 100–300 mcg once daily (gradual titration); advanced up to 500 mcg.
• Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.
• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

• Frequency: Inject once daily subcutaneously, typically in the evening before bedtime[5][6]. For ≤10-unit (≤0.10 mL) administrations (Weeks 1–2), consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Reference-derived details for DSIP 5mg.

• Draw 3.0 mL bacteriostatic water with a sterile syringe.
• Inject slowly down the vial wall; avoid foaming.
• Gently swirl/roll until dissolved (do not shake).
• Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–12 week daily protocol with gradual titration.

• Peptide Vials (DSIP, 5 mg each):
• Peptide Vials (DSIP, 5 mg each):: 8 weeks at ~200 mcg/day avg ≈ 2–3 vials
• Peptide Vials (DSIP, 5 mg each):: 12 weeks at ~200 mcg/day avg ≈ 3–4 vials
• Peptide Vials (DSIP, 5 mg each):: 12 weeks at ~300 mcg/day avg ≈ 5–6 vials
• Insulin Syringes (U-100):
• Insulin Syringes (U-100):: Per week: 7 syringes (1/day)
• Insulin Syringes (U-100):: 8 weeks: 56 syringes
• Insulin Syringes (U-100):: 12 weeks: 84 syringes
• Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
• Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 3 vials: 9 mL → 1 × 10 mL bottle
• Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 5 vials: 15 mL → 2 × 10 mL bottles
• Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 6 vials: 18 mL → 2 × 10 mL bottles
• Alcohol Swabs: One for the vial stopper + one for the injection site each day.
• Alcohol Swabs: One for the vial stopper + one for the injection site each day.: Per week: 14 swabs (2/day)
• Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 8 weeks: 112 swabs → recommend 2 × 100-count boxes
• Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 12 weeks: 168 swabs → recommend 2 × 100-count boxes

Protocol Overview

Concise summary of the once-daily regimen.

• Goal: Support healthy sleep architecture and stress modulation over time[3][4]. Open source
• Schedule: Daily subcutaneous injections for 4–8 weeks (extend to 12 weeks if desired).
• Dose Range: 100–300 mcg daily with gradual titration; advanced up to 500 mcg.
• Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

• Start: 100 mcg daily; increase by ~50 mcg every 1–2 weeks as tolerated.
• Target: 250–300 mcg daily by Weeks 4–8.
• Frequency: Once per day (subcutaneous), typically before bedtime.
• Cycle Length: 4–8 weeks; optional extension to 12 weeks with periodic breaks.
• Timing: Evening administration preferred; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[8]. Open source
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within ~4 weeks and avoid freeze–thaw[9]. Open source
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation to maintain consistency.
• Some research suggests DSIP effects may persist for multiple nights after dosing[2]; adjust frequency as needed. Open source

How This Works

DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) was first characterized in 1977 as a sleep-modulating factor isolated from rabbit brain[1]. Mechanistic studies suggest DSIP may influence sleep by modulating GABAergic transmission and interacting with opioid receptor systems[10]. Research indicates it can increase delta-wave (slow-wave) sleep duration without significantly altering REM sleep architecture[3]. Beyond sleep, DSIP has demonstrated stress-protective and adaptogenic properties in various models, potentially through modulation of the hypothalamic-pituitary-adrenal axis[4][11].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

• May promote deeper, more restorative slow-wave sleep and improve subjective sleep quality[3][5]. Open source
• Research suggests potential stress-protective and anxiolytic-like effects[4][11]. Open source
• Some studies indicate DSIP does not induce pharmacological tolerance with continued use[2]. Open source
• Generally well tolerated in human studies; occasional mild injection-site reactions may occur with subcutaneous administration.
• Limited long-term safety data; periodic breaks are recommended as a precaution[6]. Open source

Lifestyle Factors

Complementary strategies for best outcomes.

• Maintain consistent sleep-wake schedules to reinforce circadian rhythms.
• Limit blue light exposure and stimulants (caffeine, nicotine) in the hours before bed.
• Create a cool, dark, quiet sleep environment.
• Incorporate regular physical activity, ideally earlier in the day.
• Manage stress through relaxation techniques (meditation, deep breathing).

Injection Technique

General subcutaneous guidance from clinical best-practice resources[12].

• Clean the vial stopper and skin with alcohol; allow to dry.
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[12][13]. Open source
• Do not aspirate for subcutaneous injections; inject slowly and steadily[12]. Open source
• Rotate sites systematically (abdomen at least 2 inches from navel, thighs, upper arms) to avoid lipohypertrophy[13]. Open source

Recommended Source

We recommend Prime Lab Peptides for high-purity DSIP (5 mg).

• High-purity, third-party-tested lots with batch COAs.
• Consistent, ISO-aligned handling and documentation.
• Reliable fulfillment to maintain cold-chain integrity.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

• Do not start, stop, combine, or change a protocol based only on website content.
• Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References

— Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proc Natl Acad Sci USA

• DSIP (5mg Vial) Open source
• — Delta sleep-inducing peptide: editorial review of mechanisms and clinical context